JP2008524225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524225A5 JP2008524225A5 JP2007546818A JP2007546818A JP2008524225A5 JP 2008524225 A5 JP2008524225 A5 JP 2008524225A5 JP 2007546818 A JP2007546818 A JP 2007546818A JP 2007546818 A JP2007546818 A JP 2007546818A JP 2008524225 A5 JP2008524225 A5 JP 2008524225A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- butoxyiminomethylcamptothecin
- sequentially
- same time
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63643904P | 2004-12-15 | 2004-12-15 | |
| US60/636,439 | 2004-12-15 | ||
| PCT/US2005/044993 WO2006065780A2 (en) | 2004-12-15 | 2005-12-13 | Combinations of therapeutic agents for treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008524225A JP2008524225A (ja) | 2008-07-10 |
| JP2008524225A5 true JP2008524225A5 (https=) | 2009-02-05 |
| JP5345323B2 JP5345323B2 (ja) | 2013-11-20 |
Family
ID=36463409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546818A Expired - Fee Related JP5345323B2 (ja) | 2004-12-15 | 2005-12-13 | 癌を処置するための治療剤の組合せ |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8975248B2 (https=) |
| EP (1) | EP1827437B1 (https=) |
| JP (1) | JP5345323B2 (https=) |
| KR (1) | KR101367516B1 (https=) |
| CN (1) | CN101080227B (https=) |
| AT (1) | ATE531371T1 (https=) |
| AU (1) | AU2005316652B2 (https=) |
| BR (1) | BRPI0515774A (https=) |
| CA (1) | CA2589521C (https=) |
| CY (1) | CY1112368T1 (https=) |
| DK (1) | DK1827437T3 (https=) |
| ES (1) | ES2374828T3 (https=) |
| HR (1) | HRP20110960T1 (https=) |
| IL (1) | IL183595A0 (https=) |
| MA (1) | MA29096B1 (https=) |
| MX (1) | MX2007007212A (https=) |
| NO (1) | NO20073552L (https=) |
| NZ (1) | NZ555370A (https=) |
| PL (1) | PL1827437T3 (https=) |
| PT (1) | PT1827437E (https=) |
| RU (1) | RU2400232C2 (https=) |
| SI (1) | SI1827437T1 (https=) |
| TN (1) | TNSN07224A1 (https=) |
| TW (1) | TW200628151A (https=) |
| WO (1) | WO2006065780A2 (https=) |
| ZA (1) | ZA200704701B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0314042B8 (pt) | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| US8975248B2 (en) | 2004-12-15 | 2015-03-10 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Combinations of therapeutic agents for treating cancer |
| US20080219977A1 (en) * | 2005-07-27 | 2008-09-11 | Isaiah Josh Fidler | Combinations Comprising Gemcitabine and Tyrosine Kinase Inhibitors for the Treatment of Pancreatic Cancer |
| RU2487711C2 (ru) * | 2005-11-21 | 2013-07-20 | Новартис Аг | Лечение нейроэндокринных опухолей |
| WO2007094026A1 (en) * | 2006-02-17 | 2007-08-23 | Paolo La Colla | Prophylactic and/or therapeutic treatment of proliferative and conformational diseases |
| CA2645633A1 (en) * | 2006-04-05 | 2007-11-01 | Novartis Ag | Combinations of therapeutic agents for treating cancer |
| EP2606890A1 (en) * | 2006-04-05 | 2013-06-26 | Novartis AG | Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer |
| AU2007234379A1 (en) * | 2006-04-05 | 2007-10-11 | Novartis Ag. | Combinations of therapeutic agents for treating cancer |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| EP2060565A1 (en) * | 2007-11-16 | 2009-05-20 | 4Sc Ag | Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| EP2278966B1 (en) | 2008-03-21 | 2019-10-09 | The University of Chicago | Treatment with opioid antagonists and mtor inhibitors |
| CN101837129B (zh) * | 2009-03-19 | 2012-12-12 | 鼎泓国际投资（香港）有限公司 | 含cMet抑制剂、HDAC抑制剂与EGFR酪氨酸激酶抑制剂的药物组合物及其应用 |
| US20120114658A1 (en) * | 2009-09-15 | 2012-05-10 | John Ryan | Treatment of cancer |
| WO2011133479A2 (en) * | 2010-04-19 | 2011-10-27 | Niiki Pharma Inc. | Combination therapy with a proteasome inhibitor and a gallium complex |
| ME02395B (me) * | 2010-11-12 | 2016-09-20 | Pharma Mar Sa | Kombinovana terapija sa antitumorskim alkaloidima |
| CN102731516B (zh) * | 2011-04-07 | 2014-07-02 | 宁波天衡药业股份有限公司 | 一类具有抗肿瘤活性的喜树碱衍生物 |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| US20170112866A1 (en) * | 2014-04-04 | 2017-04-27 | Taiho Pharmaceutical Company Limited | Anti-tumor agent containing taxane compound, and anti-tumor effect enhancer |
| KR102359214B1 (ko) | 2014-04-04 | 2022-02-07 | 델 마 파마슈티컬스 | 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체 |
| WO2016201481A1 (en) | 2015-06-15 | 2016-12-22 | Newsouth Innovations Pty Limited | Pharmaceutical combinations of organo-arsenoxide compounds and mtor inhibitors |
| CN107951888A (zh) * | 2017-12-19 | 2018-04-24 | 天津科技大学 | 阿法替尼与10-羟基喜树碱的药物组合及其应用 |
| CN109091480A (zh) * | 2018-09-19 | 2018-12-28 | 天津科技大学 | 癌组合物10-羟基喜树碱和克唑替尼治疗肺癌及用途 |
| JPWO2020130125A1 (ja) * | 2018-12-21 | 2021-11-04 | 第一三共株式会社 | 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ |
| CN111789903A (zh) * | 2019-04-08 | 2020-10-20 | 石小和 | 治疗尿道癌的药物组合物及其制备方法 |
| JP2023503318A (ja) | 2019-11-21 | 2023-01-27 | ファルマ、マール、ソシエダード、アノニマ | ルルビネクテジン製剤で小細胞肺がんを処置する方法 |
| CN113244388A (zh) * | 2021-07-01 | 2021-08-13 | 江苏先声药业有限公司 | 抗人vegf抗体与化药联用在制备治疗卵巢癌的药物中的应用 |
| WO2023165603A1 (en) * | 2022-03-03 | 2023-09-07 | Zai Lab (Shanghai) Co., Ltd. | Dna-pk inhibitor and combination use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2206478T3 (es) | 1994-11-11 | 2004-05-16 | Debiopharm S.A. | Composiciones carcinostaticas que contienen cis-oxaliplatino y otra u otras sustancias carcinostaticas compatibles. |
| JPH08169825A (ja) * | 1994-12-15 | 1996-07-02 | Tanaka Kikinzoku Kogyo Kk | 抗癌剤の併用投与方法及び併用可能な抗癌剤 |
| SE9704545D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| US20020103141A1 (en) | 1998-12-23 | 2002-08-01 | Mckearn John P. | Antiangiogenic combination therapy for the treatment of cancer |
| US7105492B2 (en) | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| ATE216998T1 (de) * | 1999-03-09 | 2002-05-15 | Sigma Tau Ind Farmaceuti | Camptothecin-derivate mit antitumor-wirkung |
| GB0119249D0 (en) * | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
| EP1441736A2 (en) | 2001-10-29 | 2004-08-04 | Novartis AG | Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases |
| US7323479B2 (en) | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| EP1545544A2 (en) * | 2002-07-11 | 2005-06-29 | Combinatorx, Incorporated | Combinations of drugs for the treatment of neoplasms |
| CN1791396A (zh) * | 2003-05-21 | 2006-06-21 | 诺瓦提斯公司 | 组蛋白脱乙酰基酶抑制剂与化疗剂的组合 |
| MXPA06014021A (es) * | 2004-06-04 | 2007-02-08 | Pfizer Prod Inc | Procedimiento para tratar crecimiento celular anormal. |
| US8975248B2 (en) | 2004-12-15 | 2015-03-10 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Combinations of therapeutic agents for treating cancer |
| JP4702322B2 (ja) | 2006-12-14 | 2011-06-15 | トヨタ自動車株式会社 | 内燃機関の制御装置 |
-
2005
- 2005-12-13 US US11/720,776 patent/US8975248B2/en not_active Expired - Fee Related
- 2005-12-13 NZ NZ555370A patent/NZ555370A/en not_active IP Right Cessation
- 2005-12-13 EP EP05853820A patent/EP1827437B1/en not_active Expired - Lifetime
- 2005-12-13 CN CN2005800429798A patent/CN101080227B/zh not_active Expired - Lifetime
- 2005-12-13 DK DK05853820.8T patent/DK1827437T3/da active
- 2005-12-13 PT PT05853820T patent/PT1827437E/pt unknown
- 2005-12-13 MX MX2007007212A patent/MX2007007212A/es active IP Right Grant
- 2005-12-13 AU AU2005316652A patent/AU2005316652B2/en not_active Ceased
- 2005-12-13 RU RU2007126978/14A patent/RU2400232C2/ru not_active IP Right Cessation
- 2005-12-13 HR HR20110960T patent/HRP20110960T1/hr unknown
- 2005-12-13 SI SI200531442T patent/SI1827437T1/sl unknown
- 2005-12-13 WO PCT/US2005/044993 patent/WO2006065780A2/en not_active Ceased
- 2005-12-13 KR KR1020077013401A patent/KR101367516B1/ko not_active Expired - Fee Related
- 2005-12-13 BR BRPI0515774-9A patent/BRPI0515774A/pt active Search and Examination
- 2005-12-13 ES ES05853820T patent/ES2374828T3/es not_active Expired - Lifetime
- 2005-12-13 PL PL05853820T patent/PL1827437T3/pl unknown
- 2005-12-13 JP JP2007546818A patent/JP5345323B2/ja not_active Expired - Fee Related
- 2005-12-13 CA CA2589521A patent/CA2589521C/en not_active Expired - Fee Related
- 2005-12-13 AT AT05853820T patent/ATE531371T1/de active
- 2005-12-14 TW TW094144288A patent/TW200628151A/zh unknown
-
2007
- 2007-05-31 IL IL183595A patent/IL183595A0/en unknown
- 2007-06-07 ZA ZA200704701A patent/ZA200704701B/xx unknown
- 2007-06-14 TN TNP2007000224A patent/TNSN07224A1/fr unknown
- 2007-06-18 MA MA29998A patent/MA29096B1/fr unknown
- 2007-07-09 NO NO20073552A patent/NO20073552L/no not_active Application Discontinuation
-
2012
- 2012-01-20 CY CY20121100074T patent/CY1112368T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008524225A5 (https=) | ||
| RU2007126978A (ru) | Комбинации терапевтических агентов для лечения рака | |
| Judson et al. | New developments and approaches in the platinum arena | |
| ES2537352T3 (es) | Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapéuticos, y metodos para su uso | |
| RU2010117635A (ru) | Комбинированная химиотерапия | |
| JPWO2023190748A5 (https=) | ||
| JP2014512356A5 (https=) | ||
| JP2006503919A5 (https=) | ||
| NZ590431A (en) | Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor | |
| EP2127652A4 (en) | METHOD OF TREATING CANCER USING AN ANTI-CANCER AGENT IN COMBINATION | |
| RU2007141654A (ru) | Противоопухолевая комбинированная терапия, в которой используется сунитиниб-малат | |
| TW201107327A (en) | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent | |
| RU2010151602A (ru) | Комбинированная терапия с помощью рм00104 и другого противоопухолевого средства | |
| JP2019524713A5 (https=) | ||
| JP2018538260A5 (https=) | ||
| JP2011520921A5 (https=) | ||
| JP2013515690A5 (https=) | ||
| FI3773595T3 (fi) | Syöpälääkekoostumuksia yhdistelmähoitoon | |
| RU2007145932A (ru) | Способ лечения устойчивого к лекарственным средствам рака | |
| IL307990A (en) | Antimicrobial and anticancer agents | |
| TW202002989A (zh) | 抗腫瘤劑、抗腫瘤效果增強劑及抗腫瘤用試劑盒 | |
| WO2022038038A3 (en) | Pharmaceutical composition comprising a plurality of active agents for use in the treatment or prophylaxis of tumor diseases | |
| Hu et al. | Current status of CPT and its analogues in the treatment of malignancies | |
| JP2016522826A5 (https=) | ||
| Saura et al. | A Phase Ib Study of the Akt Inhibitor GDC-0068 with Docetaxel or mFOLFOX6 in Patients with Advanced Solid Tumors |